Cargando…
Decreased Serum EGF in First-episode and Chronic Schizophrenia Patients: Negative Correlation with Psychopathology
Previous studies have demonstrated that neurotrophic factors may play a critical role in the severity of clinical symptoms in schizophrenia. However, it remains unknown whether serum levels of epidermal growth factor (EGF) in schizophrenia are similar to those observed in the case of other neurotrop...
Autores principales: | Zhang, Xiaobin, Xiao, Wenhuan, Chen, KuanYu, Zhao, Yaqin, Ye, Fei, Tang, Xiaowei, Du, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162869/ https://www.ncbi.nlm.nih.gov/pubmed/32300175 http://dx.doi.org/10.1038/s41598-020-63544-0 |
Ejemplares similares
-
Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels
por: Zhao, Yaqin, et al.
Publicado: (2019) -
Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy
por: Zhang, Xiaobin, et al.
Publicado: (2020) -
Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia
por: Du, Xiangdong, et al.
Publicado: (2020) -
Psychopathology and treatment responsiveness of patients with first-episode schizophrenia
por: Češková, Eva, et al.
Publicado: (2005) -
Relating self‐disorders to neurocognitive and psychopathological measures in first‐episode schizophrenia
por: Sandsten, Karl Erik, et al.
Publicado: (2022)